Black Fungus Drug Manufactured With Expired Licences Issued During Covid; SC Raps Centre

New Delhi: The Supreme Court, on Tuesday, pulled up the Centre and the Drug Controller General of India (DCGI) for failing to act against pharmaceutical companies allegedly manufacturing and selling critical antifungal drug Liposomal Amphot